2021-01-05,SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-19,10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
2020-12-17,Is SWTX A Good Stock To Buy Now?
2020-12-15,SpringWorks Therapeutics Announces Executive Leadership Promotions
2020-12-07,We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
2020-11-24,SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference
2020-11-12,SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
2020-10-26,Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
2020-10-16,"Gamco Investors, Jana Partners Make Activist Moves"
2020-10-13,SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
2020-10-12,SpringWorks Therapeutics (SWTX) Surges: Stock Moves 9.6% Higher
2020-10-07,SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock
2020-10-07,"The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences"
2020-10-06,SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock
2020-10-06,SpringWorks Inks Deal With Pfizer for Nirogacestat Combo
2020-10-05,SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF06863135 in Patients with Relapsed or Refractory Multiple Myeloma
2020-09-22,SpringWorks Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference
2020-09-21,Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
2020-09-18,SpringWorks Therapeutics Enters into Sponsored Research Agreement with Fred Hutchinson Cancer Research Center to Further Evaluate Nirogacestat as a BCMA Potentiator in Multiple Myeloma
2020-09-16,SpringWorks Therapeutics Announces Collaboration with Childrens Oncology Group to Conduct a Phase 2 Clinical Trial of Nirogacestat in Pediatric Patients with Desmoid Tumors and Reports Publication of Nirogacestat Case Series in Pediatric/Young Adult Desmoid Tumor Patients
2020-09-14,SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
2020-08-12,SpringWorks Therapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
2020-08-04,SpringWorks Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference
2020-07-22,SpringWorks Therapeutics Announces Full Enrollment of Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Desmoid Tumors
2020-06-28,"Hedge Funds Keep Buying SpringWorks Therapeutics, Inc. (SWTX)"
2020-06-22,BeiGene and SpringWorks Announce Presentation of Preclinical Data Combining RAF Dimer Inhibitor Lifirafenib with MEK Inhibitor Mirdametinib and Provide Update on Ongoing Phase 1b/2 Clinical Trial
2020-06-22,SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and GlaxoSmithKlines Belantamab Mafodotin for the Treatment of Relapsed or Refractory Multiple Myeloma
2020-06-17,SpringWorks Therapeutics (SWTX) in Focus: Stock Moves 5.9% Higher
2020-06-10,SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Good Position To Deliver On Growth Plans
2020-06-02,SpringWorks Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-26,"SpringWorks Therapeutics Appoints Julie Hambleton, M.D. to its Board of Directors"
2020-05-12,SpringWorks Therapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights
2020-04-15,"Hedge Funds Have Never Been More Bullish On SpringWorks Therapeutics, Inc. (SWTX)"
2020-03-18,"SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Nirogacestat, Extending Patent Protection into 2039"
2020-03-12,SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
2020-02-27,"MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors"
2020-02-18,SpringWorks Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
2020-01-13,Allogene Therapeutics and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate ALLO-715 in Combination with Nirogacestat in Multiple Myeloma
2020-01-06,SpringWorks Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-16,"Hedge Funds Have Never Been This Bullish On SpringWorks Therapeutics, Inc. (SWTX)"
2019-12-13,We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth
2019-12-09,Researchers Present Preclinical Data Showing Synergistic Activity of SpringWorks Therapeutics Gamma Secretase Inhibitor (Nirogacestat) with GlaxoSmithKlines BCMA Antibody-Drug Conjugate (Belantamab Mafodotin) at the American Society of Hematology (ASH) Annual Meeting
2019-11-12,SpringWorks Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
2019-10-24,SpringWorks Therapeutics Announces Initiation of Phase 2b ReNeu Clinical Trial of Mirdametinib in Children and Adults with Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas (NF1-PN)
2019-09-27,"Beacon Roofing, Sunrun, Marchex and Other 13D Filings"
2019-09-24,European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma
2019-09-17,SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares
2019-09-13,"Cloudflare IPO Prices Above Range, Raises $525 Million"
2019-09-12,SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
